Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Aug;21(8):3627-3628.
doi: 10.1111/jocd.14976. Epub 2022 Apr 12.

Commentary on "Potential risk factors for Varicella-zoster virus reactivation after COVID-19 vaccination"

Dursun Turkmen  1 , Nihal Altunisik  1 , Sibel Altunisik Toplu  2
Affiliations
Comment

Commentary on "Potential risk factors for Varicella-zoster virus reactivation after COVID-19 vaccination"

Dursun Turkmen et al. J Cosmet Dermatol. 2022 Aug.
No abstract available

Keywords: herpes zoster reactivation; inactivated SARS-CoV-2 vaccine; varicella-zoster virus.

PubMed Disclaimer

Conflict of interest statement

We declare that there is no conflict of interest of all authors in this work. No financial support was provided for the conduct, collection, preparation, interpretation, analysis, and writing of the report. Informed consent and permission for publication of medical images were obtained from the patient.

Figures

FIGURE 1
FIGURE 1
(A and B) Clinical appearance of case 1, (C) clinical appearance of case 2 at first admission; (D and E) appearance of case 2 on the fifth day of treatment
See this image and copyright information in PMC

Comment on

References

    1. May Lee M, Macchi S, Mora E, Feliciani C. Potential risk factors for Varicella‐zoster virus reactivation after COVID‐19 vaccination. J Cosmet Dermatol. 2022;21(4):1347‐1349. 10.1111/jocd.14871 - DOI - PMC - PubMed
    1. Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212‐e213. - PubMed
    1. Wollina U, Karadağ AS, Rowland‐Payne C, Chiriac A, Lotti T. Cutaneous signs in COVID‐19 patients: a review. Dermatol Ther. 2020;33(5):e13549. - PMC - PubMed
    1. Turkmen D, Altunisik N, Mantar I, Durmaz I, Sener S, Colak C. Comparison of patients’ diagnoses in a dermatology outpatient clinic during the COVID‐19 pandemic period and pre‐pandemic period. Int J Clin Pract. 2021;75(4):e13948. - PMC - PubMed
    1. Sharma O, Sultan AA, Ding H, Triggle CR. A review of the progress and challenges of developing a vaccine for COVID‐19. Front Immunol. 2020;11:585354. - PMC - PubMed

Substances